On Demand: The Future of Lung Cancer Screening for All Communities in RI: Where We Are and Where We Need to Be
Brown University via Independent
After participating in this course, the learner should be better able to:
- Describe the new USPSTF Lung Cancer Screening recommendations.
- Identify systems and promising practices to increase screening rates in high-risk populations.
- Recognize the stigma associated with lung cancer and initiate motivational interviewing in your system.
- Recognize and assess disparities in access to lung cancer screening rates across demographics.
- Identify and provide appropriate cessation resources applicable to the needs of patients.
- Formulate a plan in your practice to assess newly updated eligibility for lung cancer screening.
- Formulate a plan to integrate lung cancer screening eligibility alerts into electronic health records.
- Identify tools to increase data collection to assess eligibility for lung cancer screening among Rhode Islanders.
Method of Participation and How to Receive CME Credit
There are no fees for participating in and receiving credit for this activity.
Review the activity objectives, disclosures, and CME information prior to participating in the activity.
View the webinar recording
Complete the CME activity evaluation at the conclusion of the activity in order to receive a credit certificate.
In accordance with the disclosure policy of the Brown University CME Office as well as standards set forth by the Accreditation Council on Continuing Medical Education (ACCME), speakers have been asked to disclose any relevant financial relationship with the manufacturers of any commercial products and/or provider of commercial services discussed in any educational presentation and with any commercial supporters or exhibitors of this activity.
The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation but to identified openly so that the listener may form his/her own opinion. Any potential conflicts of interest have been resolved prior to this presentation.
This activity may include discussion of off-label or investigative drugs uses. Speakers are aware that it is their responsibility to disclose to the audience this information. Individual Faculty Disclosure information may be found in the conference handouts.
Speaker & Planner Financial Disclosures
The following speakers and planning committee members* have disclosed that they have no relevant financial relationships:
Julia Doherty, MPH, MSW*
Norma V Hardy M.Ed. CHES*
Dan Fitzgerald, MPH, ICPS*
George Andoscia, MPH*
Terrance Healey, MD*
Lynn Basilio, MS*
Ross Hilliard, MD, FACP
Angela Butler, BIS, RRT- NPS, CPFT, NCTTP, AE-C*
Jennifer Wall*Kristen Hubbard, MDMegan Daniel*
Siana Wood, RN, BSN, CDOE*Linda Nici, MD
Joe Dziobek, MSW*
Disclaimer: This educational program is designed to present scientific information and opinion to Health professionals, to stimulate thought, and further investigation.
This webinar was supported by Cooperative Agreement Number NU58DP006291, funded by the Centers for Disease Control and Prevention and awarded to the Rhode Island Department of Health. Its contents are solely the responsibility of the presenters and do not necessarily represent the official views of the Centers for Disease Control and Prevention, the Department of Health and Human Services, or the Rhode Island Department of Health.